ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #9,307Top JournalReview JournalHybrid

Current Pharmaceutical Design

Abbreviation (ISO):CURR. PHARM. DES
•
Identifier (ISSN):1381-6128(Print)/1873-4286(Online)
•
Publisher:Bentham Science Publishers B.V.
Clarivate IF (2026)
3.2↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Current Pharmaceutical Design

WoS Q2
12452.7620182.4120192.2120203.1220213.3120223.120232.620242.820253.22026
Annual Impact Factor Metric
Current (2026):3.2
Scopus SJR & RankScopus Q2
0.632
#9,307

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
197

197 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
397articles/year
4.5% Gold OA•25.34% Original Research

Aims & Scope

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field. Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Topics Covered (Recognized by AI)
Medicine93.9%Biology93.5%Chemistry75.5%Internal medicine74.5%Biochemistry68.5%Genetics68.2%Psychology42.1%Pathology39.4%Pharmacology34.8%Endocrinology34.8%Psychiatry33.1%Organic chemistry31.9%Physics31.1%Immunology30%Gene24.2%Cell biology22.6%Bioinformatics22.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank156/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank237/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.2
Articles / Year337
Total Citations90
2025
IF2.8
Articles / Year327
Total Citations762
2024
IF2.6
Articles / Year327
Total Citations1,987
2023
IF3.1
Articles / Year301
Total Citations2,507
2022
IF3.31
Articles / Year317
Total Citations3,491

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,307Scopus Q2SCImago Profile
Scopus Coverage:1995-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.632

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.35

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,026 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,057
3-Year Documents899
Citable Documents827

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ2
PharmacologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Pharmaceutical Design (abbr: CURR. PHARM. DES, ISSN: 1381-6128) is a peer-reviewed international scholarly journal in the field of Medicine, published by Bentham Science Publishers B.V. in Netherlands since 1995. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.632 (Q2), an H-index of 197.

The journal enforces rigorous peer evaluation with a publication frequency of Biweekly, an annual output of approximately 397 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,026 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Bentham Science Publishers B.V.
Publication Language
English
Frequency
Biweekly
Founding Year
1995
Indexing & Databases
SCIEScopusPubMed
Editorial Address
BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c252deba-e2ee-48e4-8243-2bd848fde13f
Database Updated: 2026-10-01